ISSCA Announces Upcoming Regenerative Medicine Conference In Iraq
The International Society for Stem Cell Application (ISSCA) is pleased to announce one of the most exciting conferences of the year – the Regenerative Medicine Conference. The conference will take place at the Plaza Hotel-Kirkuk Iraq, on November 11, 2022.
About the Regenerative Medicine Conference 2022
The goal of the conference is to encourage more physicians to utilize methods of practicing regenerative medicine so that it can be readily available to patients globally, especially in countries where advanced medical procedures aren’t normally accessible.
The ideal participants are physicians and specialists in Iraq who want to further their education in regenerative medicine, and learn how to incorporate various cell therapies into their practice.
Participants will gain exclusive access to the latest state-of-the-art technologies of biologics and regenerative medicine products and learn how they are applicable. Furthermore, participants will acquire knowledge on how regenerative medicine can play a major role in developing solutions for current problems in the medical field, ultimately allowing them to provide better treatment for their patients.
The Main Speakers of the Regenerative Medicine Conference 2022
The Regenerative Medicine Conference features a two-fold curriculum:
- A theoretical portion where four leading world-class medical specialists will share their knowledge and experience with participants via lectures; and
- A practical portion where participants will be trained on applying the clinical and aesthetic methods of stem cell therapy. In this portion, physicians will learn the proper protocols to safely and effectively apply these methods.
ISSCA is proud to announce the following speakers:
- M. Salih Yildirim, ISSCA’s Head of the Middle East Operations
- Mehmet Veli Karaaltin, Founder of Dr. Karaaltin Clinic, an Aesthetic, Plastic, and Reconstructive Surgery Clinic
- Melih Can Sezhic, Plastic Reconstructive, and Aesthetic Surgeon & Regenerative Medicine Specialist
- Hilmi Karadeniz, Doctor of Medicine, Specializing in Orthopedics and Traumatology
Sponsors
ISSCA would like to thank the people who are making this conference possible
- Global Stem Cells Group
- Regen Clinic
- Biotrend
- Karaaltin
- Sportoteam
Without the generosity of these people and brands, the Regenerative Medicine Conference would not be able to exist, and ISSCA is extremely thankful for the support.
About the International Society for Stem Cell Application
The International Society for Stem Cell Application (ISSCA) is a multifaceted community of physicians and scientists with a shared mission to treat diseases and lessen human suffering through advances in science, technology, and regenerative medicine. ISSCA strives to serve its members by continuing to advance in the field of regenerative medicine
ISSCA’s vision is for its members to become world leaders in setting standards and promoting excellence in regenerative medicine, related education, certification, research, and publications.
ISSCA understands that physicians need to keep their education and skills current, which is why ISSCA is holding this exciting Regenerative Medicine Conference in Iraq. Moreover, ISSCA offers certification training in cities all across the globe to encourage participants to practice regenerative medicine and make it widely accessible to patients everywhere.
Are you looking to further your education in regenerative medicine? Don’t miss out on this opportunity! To participate in this year’s Regenerative Medicine Conference, contact us on our website
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in Press Releases